USING AI AND NEUROIMAGING
ADVANCED CLINICAL TRIALS AND THERAPIES
OPTIMIZED THERAPIES
OPTIMAL MEASURES
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
NEWS
https://www.qynapse.com/wp-content/uploads/2020/10/Qynapse-TPMD-thumbnail.png
1125
1400
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-10-13 07:09:222020-10-13 07:11:04QYNAPSE (France) and TRUE POSITIVE MEDICAL DEVICES (Canada) are partnering to provide the most advanced AI platform for brain diseases
https://www.qynapse.com/wp-content/uploads/2020/09/World-Alzheimer-Day_brain_website.png
703
1641
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-21 07:43:142020-09-21 07:43:14World Alzheimer's Day: Neuroimaging and artificial intelligence offer new opportunities for patients
https://www.qynapse.com/wp-content/uploads/2020/10/MS-data-thumbnail-v4.png
1125
1400
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-16 16:33:552020-10-12 10:37:54Qynapse releases new data demonstrating the value of QyScore® for the clinical assessment of Multiple Sclerosis (MS)
https://www.qynapse.com/wp-content/uploads/2020/10/MsVirtual-thumbnailv3.png
720
896
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-09-07 10:22:432020-10-12 10:24:17Qynapse sponsors the 8th joint ACTRIMS-ECTRIMS meeting – MSVirtual2020
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
